MLTX - MoonLake Immunotherapeutics

QQQ $ 473.14 $ -2.10 (-0.44 %)

DIA $ 417.33 $ 2.44 (0.59 %)

SPY $ 562.48 $ 0.83 (0.15 %)

TLT $ 101.29 $ 0.92 (0.92 %)

GLD $ 238.61 $ -0.02 (-0.01 %)

Previous Close

$ 49.98

Open

$ 50.85

Bid

$ 37.98 x 100

Ask

-- x --

Day's Range

$ 50.06 - $ 51.48

52 Week Range

$ 35.11 - $ 64.98

Volume

230,633

Average Volume

Market Cap

3.19B

Beta (5Y Monthly)

$ 0.65

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2024	06-30-2024	10-Q
2	05-07-2024	03-31-2024	10-Q
3	02-29-2024	12-31-2023	10-K
4	11-14-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-20-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-12-2022	06-30-2022	10-Q
10	05-16-2022	03-31-2022	10-Q
11	02-17-2022	12-31-2021	10-K
12	11-12-2021	09-30-2021	10-Q
13	08-16-2021	06-30-2021	10-Q
14	05-21-2021	03-31-2021	10-Q
15	03-31-2021	12-31-2020	10-K
16	12-03-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Moon...
09/12/2024 10:27:11

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $100 price tar...

Needham Reiterates Buy on MoonLake, Mainta...
09/12/2024 09:55:57

Needham analyst Serge Belanger reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $62 price target.

Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 17:18:39

Cantor Fitzgerald analyst Prakhar Agrawal reiterates MoonLake (NASDAQ:MLTX) with a Overweight.

Wolfe Research Downgrades MoonLake to Peer...
08/26/2024 10:31:40

Wolfe Research analyst Andy Chen downgrades MoonLake (NASDAQ:MLTX) from Outperform to Peer Perform.

Needham Maintains Buy on MoonLake, Lowers ...
08/08/2024 10:21:59

Needham analyst Serge Belanger maintains MoonLake (NASDAQ:MLTX) with a Buy and lowers the price target from $66 to $62.

MoonLake Q2 2024 Adj EPS $(0.39) Misses $(...
08/07/2024 12:41:46

MoonLake (NASDAQ:MLTX) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.28) by...

HC Wainwright & Co. Reiterates Buy on Moon...
07/01/2024 10:41:35

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $100 price tar...

Oppenheimer Initiates Coverage On MoonLake...
06/25/2024 09:48:05

Oppenheimer analyst Andreas Argyrides initiates coverage on MoonLake (NASDAQ:MLTX) with a Outperform rating and announces Pr...

HC Wainwright & Co. Reiterates Buy on Moon...
06/11/2024 10:35:44

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $100 price tar...

Needham Reiterates Buy on MoonLake, Mainta...
06/10/2024 17:49:09

Needham analyst Serge Belanger reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $66 price target.

MoonLake Immunotherapeutics Says FDA And E...
06/10/2024 12:04:21

HC Wainwright & Co. Reiterates Buy on Moon...
05/17/2024 14:17:36

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $100 price tar...

Moonlake Immunotherapeutics Begins Phase 3...
05/16/2024 12:10:32

MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidrad...

why-diodes-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Diodes Shares Are Trading Lower By Aro...
05/10/2024 16:44:44

HC Wainwright & Co. Reiterates Buy on Moon...
05/08/2024 19:16:24

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $100 price tar...

Needham Reiterates Buy on MoonLake, Mainta...
05/08/2024 09:53:17

Needham analyst Serge Belanger reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $66 price target.

MoonLake Q1 EPS $(0.22) Misses $(0.20) Est...
05/07/2024 12:09:48

MoonLake (NASDAQ:MLTX) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.20) by...

HC Wainwright & Co. Reiterates Buy on Moon...
04/23/2024 10:26:47

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $100 price tar...

HC Wainwright & Co. Reiterates Buy on Moon...
04/11/2024 11:27:28

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $100 price tar...

Moonlake Immunotherapeutics Penned Three-y...
04/10/2024 11:06:15